226 related articles for article (PubMed ID: 17096395)
1. Open-chest 31P magnetic resonance spectroscopy of mouse heart at 4.7 Tesla.
Lee J; Hu Q; Nakamura Y; Wang X; Zhang X; Zhu X; Chen W; Yang Q; Zhang J
J Magn Reson Imaging; 2006 Dec; 24(6):1269-76. PubMed ID: 17096395
[TBL] [Abstract][Full Text] [Related]
2. In vivo mouse myocardial (31)P MRS using three-dimensional image-selected in vivo spectroscopy (3D ISIS): technical considerations and biochemical validations.
Bakermans AJ; Abdurrachim D; van Nierop BJ; Koeman A; van der Kroon I; Baartscheer A; Schumacher CA; Strijkers GJ; Houten SM; Zuurbier CJ; Nicolay K; Prompers JJ
NMR Biomed; 2015 Oct; 28(10):1218-27. PubMed ID: 26269430
[TBL] [Abstract][Full Text] [Related]
3. Detection of myocardial infarctions by acquisition-weighted 31P-MR spectroscopy in humans.
Beer M; Spindler M; Sandstede JJ; Remmert H; Beer S; Köstler H; Hahn D
J Magn Reson Imaging; 2004 Nov; 20(5):798-802. PubMed ID: 15503333
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of human cardiac 31P-NMR spectroscopy.
Lamb HJ; Doornbos J; den Hollander JA; Luyten PR; Beyerbacht HP; van der Wall EE; de Roos A
NMR Biomed; 1996 Aug; 9(5):217-27. PubMed ID: 9068003
[TBL] [Abstract][Full Text] [Related]
5. [Localized 31 phosphorus NMR spectroscopy of the human heart--development of a measuring method and initial clinical application].
Friedrich M; Weikl A; Sauter R; Reinhardt ER; Bachmann K
Z Kardiol; 1991 Apr; 80(4):266-71. PubMed ID: 1862667
[TBL] [Abstract][Full Text] [Related]
6. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
[TBL] [Abstract][Full Text] [Related]
7. [The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function].
Beer M; Landschütz W; Meininger M; Seyfarth T; Viehrig M; Sandstede J; Pabst T; Kenn W; Horn M; Harre K; von Kienlin M; Neubauer S; Hahn D
Rofo; 1999 Jul; 171(1):65-8. PubMed ID: 10464508
[TBL] [Abstract][Full Text] [Related]
8. Impaired resting muscle energetics studied by (31)P-NMR in diet-induced obese rats.
Chanseaume E; Bielicki G; Tardy AL; Renou JP; Freyssenet D; Boirie Y; Morio B
Obesity (Silver Spring); 2008 Mar; 16(3):572-7. PubMed ID: 18239558
[TBL] [Abstract][Full Text] [Related]
9. [In-vivo 31P-NMR-spectroscopy in patients with dilated cardiomyopathy].
Kaiser WA; Pauleit D; Träber F; Köhler U; Reiser M
Rofo; 1992 Nov; 157(5):458-65. PubMed ID: 1421186
[TBL] [Abstract][Full Text] [Related]
10. Detection of phosphomonoester signals in proton-decoupled 31P NMR spectra of the myocardium of patients with myocardial hypertrophy.
Jung WI; Sieverding L; Breuer J; Schmidt O; Widmaier S; Bunse M; van Erckelens F; Apitz J; Dietze GJ; Lutz O
J Magn Reson; 1998 Jul; 133(1):232-5. PubMed ID: 9654494
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium.
Bottomley PA; Weiss RG
Radiology; 2001 May; 219(2):411-8. PubMed ID: 11323465
[TBL] [Abstract][Full Text] [Related]
12. Early metabolic response to tumor necrosis factor in mouse sarcoma: a phosphorus-31 nuclear magnetic resonance study.
Shine N; Palladino MA; Patton JS; Deisseroth A; Karczmar GS; Matson GB; Weiner MW
Cancer Res; 1989 Apr; 49(8):2123-7. PubMed ID: 2702653
[TBL] [Abstract][Full Text] [Related]
13. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
14. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
15. Clinical cardiac magnetic resonance spectroscopy--present state and future directions.
Neubauer S; Horn M; Hahn D; Kochsiek K
Mol Cell Biochem; 1998 Jul; 184(1-2):439-43. PubMed ID: 9746338
[TBL] [Abstract][Full Text] [Related]
16. (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.
Shivu GN; Abozguia K; Phan TT; Ahmed I; Henning A; Frenneaux M
Eur J Radiol; 2010 Feb; 73(2):255-9. PubMed ID: 19056193
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopy of ischemic heart disease.
Sardanelli F; Zandrino F; Molinari G; Cordone S; Delfino L; Levrero F
Rays; 1999; 24(1):149-64. PubMed ID: 10358392
[TBL] [Abstract][Full Text] [Related]
18. K+ transport and energetics in Kir6.2(-/-) mouse hearts assessed by 87Rb and 31P magnetic resonance and optical spectroscopy.
Jilkina O; Kuzio B; Rendell J; Xiang B; Kupriyanov VV
J Mol Cell Cardiol; 2006 Nov; 41(5):893-901. PubMed ID: 16962131
[TBL] [Abstract][Full Text] [Related]
19. [A new method to evaluate myocardial preservation techniques (author's transl)].
Menasché P; Piwnica A; Ingwall JS; Fossel ET
Nouv Presse Med; 1981 Feb; 10(5):295-8. PubMed ID: 7232182
[TBL] [Abstract][Full Text] [Related]
20. [Cardiac imaging by nuclear magnetic resonance. II. Spectroscopy].
Lanzer PA
Z Kardiol; 1986 Aug; 75(8):449-62. PubMed ID: 3535275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
